AFS MEDICAL
ActiveAFS MEDICAL has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €79k and a net result of €38k. Its solvency ranks better than 79% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
97
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+11
Growth52
Track record82
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days only on tighter terms
Liquidity ample (current ratio 6.92 against 1.89 in 2024; short-term debt: 12.7% and cash: 53.6% of total assets), and 13% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
87%
Return on assets
41.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
15 d early
2024
17 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€79k▲ 90.7%
2024 · €41k
2024: €41k
2024 → 2025
Total assets
€91k▲ 39.9%
2024 · €65k
2024: €65k
2024 → 2025
Net result
€38k▼ 4.7%
2024 · €39k
2024: €39k
2024 → 2025
Working capital
€68k▲ 230%
2024 · €21k
2024: €21k
2024 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20242025Trend
Equity€41k-€79k▲ 90.7%
Operating result€56k-€48k▼ 13.1%
Net result€39k-€38k▼ 4.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €91k
Fixed assets
€11k▼ 47.2%
Current assets
€80k▲ 81.7%
Equity and liabilities €91k
Equity
€79k▲ 90.7%
Debt
€12k▼ 49.6%
The debt ratio falls from 36.2% to 13.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€58k▼
2024 · €68k
Cash flow
€47k▼
2024 · €52k
Solvency
87.0%▲
2024 · 63.8%
Current ratio
6.92▲
2024 · 1.89
Quick ratio
6.92▲
2024 · 1.89
Debt / equity
0.15▼
2024 · 0.57
ROE
47.6%▼
2024 · 95.2%
ROA
41.4%▼
2024 · 60.7%
Interest coverage
1050.94▼
2024 · 1179.92
Debt
€12k▼
2024 · €23k
Debt ≤ 1 year
€12k▼
2024 · €23k
Income taxes
€11k▼
2024 · €16k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€65k€91k▲
Formation expenses20€0-
Fixed assets21/28€21k€11k▼
Tangible fixed assets22/27€21k€11k▼
Furniture and vehicles24€19k€9k▼
Other tangible fixed assets26€2k€2k▼
Current assets29/58€44k€80k▲
Amounts receivable within one year40/41€22k€29k▲
Trade receivables40€22k€26k▲
Other amounts receivable41€694€3k▲
Cash at bank and in hand54/58€19k€49k▲
Deferred charges and accrued income490/1€2k€2k▼
Equity and liabilities
Total equity and liabilities10/49€65k€91k▲
Equity10/15€41k€79k▲
Contributions10/11€2k€2k=
Reserves13€39k€77k▲
Distributable reserves133€39k€77k▲
Amounts payable17/49€23k€12k▼
Amounts payable within one year42/48€23k€12k▼
Trade debts44€1k€2k▲
Suppliers440/4€1k€2k▲
Taxes, remuneration and social security45€9k€8k▼
Taxes450/3€9k€8k▼
Other amounts payable47/48€13k€2k▼
Accrued charges and deferred income492/3€303€313▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€10k▼
Other operating charges640/8€3k€1k▼
Gross operating margin9900€71k€60k▼
Operating profit (loss)9901€56k€48k▼
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€58€56▼
Recurring financial charges65€58€56▼
Profit (loss) for the period before taxes9903€56k€48k▼
Income taxes67/77€16k€11k▼
Profit (loss) for the period9904€39k€38k▼
Profit (loss) for the period to be appropriated9905€39k€38k▼
Appropriation of the result
Profit (loss) to be appropriated9906€39k€38k▼
Transfer to equity691/2€39k€38k▼
To other reserves6921€39k€38k▼
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
16-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity quadruplescurrent ratio 6.92
Current ratio from 1.89 to 6.92; short-term debt falls from €23k to €12k.
14-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Welkenraedt · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hockelbach 54841 WelkenraedtGround area
1,068 m²
Building footprint
112 m²
Volume, LiDAR
694 m³
Parcel 63032D0031/00E000, Wallonia · tallest building 7.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
AFS MEDICAL
since 20242.355.355.186
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63032D0031/00E000 | Wallonia | 1,068 m² | 1 · 112 m² | 7.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Laura Van Der Linden
BE 0741.495.417
Aartselaar · Eq €79k
Dr Maude Kasel
BE 0727.486.340
Ukkel · Eq €79k
De Bries
BE 1024.563.884
Merksplas · Eq €79k
Dokter Vanduynslager Tine
BE 0672.967.588
Roeselare · Eq €79k
Van Merhaeghe Lynn huisarts
BE 1001.174.117
Maarkedal · Eq €79k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,079 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded11-01-2024
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.